GGrantIndex
← Leaderboards

Deepa Bedi

Tuskegee University

$3,768,556
Attributed
$3,768,556
Total exposure
4
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $5.3M · FY201625
$10M$7.5M$5M$2.5M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$16,176,205 · 5

By mechanism

U54$13,462,742 · 2
SC1$1,450,730 · 1
UG3$821,733 · 1
SC2$441,000 · 1

Top collaborators

Most similar at Tuskegee University

Same institution · by research overlap

Others in their field

Top investigators on “Malignant Breast Neoplasm

Research focus

Malignant Breast NeoplasmTumorPhenotypeMalignant NeoplasmsPlayComplexBioinformaticsEvaluationFundingUniversitiesBreast Cancer PatientBreast Cancer ProgressionProgramsDisease ProgressionMinority GroupsBlack RaceMorphologyHealth DisparityInfrastructureBiomedical ResearchCommunitiesAlabamaDistantCancer Cell

Grant awards (14)

Tuskegee University Center for Biomedical Research/ RCMI$3,703,230
U54 · FY2025 · MD · contact PI
Role of obesity as a causative factor of breast cancer in women of African American ethnicity$348,753
U54 · FY2025 · MD · contact PI
Tuskegee University Center for Biomedical Research/ RCMI$4,103,661
U54 · FY2024 · MD · contact PI
Carver Genomic Research Center (CGRC)-Building Next Generation Genomic Data Scientist in Rural Alabama$821,733
UG3 · FY2024 · HG · contact PI
Role of obesity as a causative factor of breast cancer in women of African American ethnicity$365,447
U54 · FY2024 · MD · contact PI
Tuskegee University Center for Biomedical Research/ RCMI$4,600,758
U54 · FY2023 · MD · contact PI
Evaluation of HSPD1 (Heat Shock Protein, 60) as a theranostic target for breast cancer$367,500
SC1 · FY2023 · GM · contact PI
Role of obesity as a causative factor of breast cancer in women of African American ethnicity$340,893
U54 · FY2023 · MD · contact PI
Evaluation of HSPD1 (Heat Shock Protein, 60) as a theranostic target for breast cancer$367,500
SC1 · FY2022 · GM · contact PI
Evaluation of HSPD1 (Heat Shock Protein, 60) as a theranostic target for breast cancer$367,500
SC1 · FY2021 · GM · contact PI
Evaluation of HSPD1 (Heat Shock Protein, 60) as a theranostic target for breast cancer$348,230
SC1 · FY2020 · GM · contact PI
Phage Display to Identify Epithelial to Mesenchymal Transitioned (EMT) Breast Cancer Cells$147,000
SC2 · FY2018 · CA · contact PI
Phage Display to Identify Epithelial to Mesenchymal Transitioned (EMT) Breast Cancer Cells$147,000
SC2 · FY2017 · CA · contact PI
Phage Display to Identify Epithelial to Mesenchymal Transitioned (EMT) Breast Cancer Cells$147,000
SC2 · FY2016 · CA · contact PI